105 related articles for article (PubMed ID: 25341598)
1. The influence of IgM-enriched immunoglobulin therapy on neonatal mortality and hematological variables in newborn infants with blood culture-proven sepsis.
Abbasoğlu A; Ecevit A; Tuğcu AU; Yapakçı E; Tekindal MA; Tarcan A; Ecevit Z
Turk J Pediatr; 2014; 56(3):267-71. PubMed ID: 25341598
[TBL] [Abstract][Full Text] [Related]
2. The influence of IgM-enriched immunoglobulin therapy on neonatal mortality and hematological variables in newborn infants with blood culture-proven sepsis.
Capasso L; Raimondi F
Turk J Pediatr; 2014; 56(5):568. PubMed ID: 26022600
[No Abstract] [Full Text] [Related]
3. IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis.
Haque KN; Zaidi MH; Bahakim H
Am J Dis Child; 1988 Dec; 142(12):1293-6. PubMed ID: 3195529
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis.
Haque KN; Remo C; Bahakim H
Clin Exp Immunol; 1995 Aug; 101(2):328-33. PubMed ID: 7648717
[TBL] [Abstract][Full Text] [Related]
5. The use of IgM-enriched intravenous immunoglobulin for the treatment of neonatal sepsis in preterm infants.
Erdem G; Yurdakök M; Tekinalp G; Ersoy F
Turk J Pediatr; 1993; 35(4):277-81. PubMed ID: 8160279
[TBL] [Abstract][Full Text] [Related]
6. Role of pentoxifylline and/or IgM-enriched intravenous immunoglobulin in the management of neonatal sepsis.
Akdag A; Dilmen U; Haque K; Dilli D; Erdeve O; Goekmen T
Am J Perinatol; 2014 Nov; 31(10):905-12. PubMed ID: 24515621
[TBL] [Abstract][Full Text] [Related]
7. Association Between Antibiotic Use and Neonatal Mortality and Morbidities in Very Low-Birth-Weight Infants Without Culture-Proven Sepsis or Necrotizing Enterocolitis.
Ting JY; Synnes A; Roberts A; Deshpandey A; Dow K; Yoon EW; Lee KS; Dobson S; Lee SK; Shah PS;
JAMA Pediatr; 2016 Dec; 170(12):1181-1187. PubMed ID: 27775765
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
9. Exchange transfusion or intravenous immunoglobulin therapy as an adjunct to antibiotics for neonatal sepsis in developing countries: a pilot study.
Gunes T; Koklu E; Buyukkayhan D; Kurtoglu S; Karakukcu M; Patiroglu T
Ann Trop Paediatr; 2006 Mar; 26(1):39-42. PubMed ID: 16494703
[TBL] [Abstract][Full Text] [Related]
10. Pentaglobin (immunoglobulin M-enriched immunoglobulin) as adjuvant therapy for premature and very low-birth-weight neonates with sepsis.
Nassir KF; Al-Saddi YI; Abbas HM; Al Khames Aga QA; Al Khames Aga LA; Oudah AA
Indian J Pharmacol; 2021; 53(5):364-370. PubMed ID: 34854404
[TBL] [Abstract][Full Text] [Related]
11. The effects of adjuvant immunoglobulin M-enriched immunoglobulin therapy on mortality rate and renal function in sepsis-induced multiple organ dysfunction syndrome: retrospective analysis of intensive care unit patients.
Yavuz L; Aynali G; Aynali A; Alaca A; Kutuk S; Ceylan BG
J Int Med Res; 2012; 40(3):1166-74. PubMed ID: 22906291
[TBL] [Abstract][Full Text] [Related]
12. Culture-proven neonatal sepsis in preterm infants in a neonatal intensive care unit over a 7 year period: coagulase-negative Staphylococcus as the predominant pathogen.
Ozkan H; Cetinkaya M; Koksal N; Celebi S; Hacımustafaoglu M
Pediatr Int; 2014 Feb; 56(1):60-6. PubMed ID: 24003995
[TBL] [Abstract][Full Text] [Related]
13. Are IgM-enriched immunoglobulins an effective adjuvant in septic VLBW infants?
Capasso L; Borrelli AC; Parrella C; Lama S; Ferrara T; Coppola C; Catania MR; Iula VD; Raimondi F
Ital J Pediatr; 2013 Oct; 39():63. PubMed ID: 24098953
[TBL] [Abstract][Full Text] [Related]
14. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
Janković B; Pasić S; Marković M; Veljković D; Milicić M
Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
[TBL] [Abstract][Full Text] [Related]
15. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.
Norrby-Teglund A; Haque KN; Hammarström L
J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001
[TBL] [Abstract][Full Text] [Related]
16. IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study.
Wand S; Klages M; Kirbach C; Warszawska J; Meybohm P; Zacharowski K; Koch A
PLoS One; 2016; 11(8):e0160907. PubMed ID: 27504630
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin in the treatment of full-term and premature newborns with sepsis.
Chen JY
J Formos Med Assoc; 1996 Nov; 95(11):839-44. PubMed ID: 8990771
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin for prophylaxis of nosocomial sepsis.
Atici A; Satar M; Karabay A; Yilmaz M
Indian J Pediatr; 1996; 63(4):517-21. PubMed ID: 10832472
[TBL] [Abstract][Full Text] [Related]
19. IgM and IgA enriched polyclonal immunoglobulins reduce short term mortality in extremely low birth weight infants with sepsis: a retrospective cohort study.
Capasso L; Borrelli AC; Pirozzi MR; Bucci L; Albachiara R; Ferrara T; Raimondi F
Minerva Pediatr (Torino); 2021 Feb; 73(1):3-7. PubMed ID: 29460549
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia.
Shitaye D; Asrat D; Woldeamanuel Y; Worku B
Ethiop Med J; 2010 Jan; 48(1):11-21. PubMed ID: 20607993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
